Table:
begin	end	state
1	11	cytoplasmic
12	32	transmembrane
33	37	non-cytoplasmic
38	56	transmembrane
57	77	cytoplasmic
78	103	transmembrane
104	116	non-cytoplasmic
117	136	transmembrane
137	145	cytoplasmic
146	169	transmembrane
170	189	non-cytoplasmic
190	213	transmembrane
214	232	cytoplasmic
233	254	transmembrane
255	278	non-cytoplasmic
279	304	transmembrane
305	324	cytoplasmic
325	346	transmembrane
347	351	non-cytoplasmic
352	372	transmembrane
373	392	cytoplasmic
393	416	transmembrane
417	422	non-cytoplasmic
423	440	transmembrane
441	454	cytoplasmic

Input:
>PfGW456L13_2756
LAQGFKPRHVTMLSIAGIIGAGLFVGSGHAIAAAGPAVLLAYLFSGLLVVLVMRMLGEMA
VANPDTGSFSTYADQAIGRWAGFTIGWLYWWFWVLVIPIEALAAGHVLNQWFPQIDAWLF
ALVSIIALVITNLFSVSKYGEFEFWFAMAKVVAIIGFIGVGFAVLMGWVPDREVSGLSGL
MAEHGGFAPNGLSAVVGAFITIMFSFIGTEAVTIAAAESDNPSQNIAKATRSVIWRIGVF
YLLSIFVVISVVPWNDPLLAQVGSYQRALEIMNIPHAKFMVDVVVLIAVASCMNSSIYIA
SRMLYSLGRRGDAPKSLKATSSEGVPRAAVIASTVLGAAITVWSYFMPAGLFNFLLASSG
AIALLVYLAIAVSQLRMRRMLRRQNIELTFRMWLFPWLTWLVIAFICAALAVMMITPEHR
TEVSTTIGLALAISFIGLVTSRHPAQAARVTSVG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server